Eric Mosbrooker is SVP, Orphan Business Unit of Horizon Therapeutics Public Ltd Co. Currently has a direct ownership of 3,585 shares of HZNP, which is worth approximately $0. The most recent transaction as insider was on Nov 01, 2017, when has been sold 2,315 shares (Ordinary Shares) at a price of $13.83 per share, resulting in proceeds of $32,016. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.59K
0% 3M change
0% 12M change
Total Value Held $0

Eric Mosbrooker Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2017
SELL
Payment of exercise price or tax liability
$32,016 $13.83 p/Share
2,315 Reduced 39.24%
3,585 Ordinary Shares
Nov 01 2017
BUY
Exercise of conversion of derivative security
-
4,435 Added 42.91%
5,900 Ordinary Shares

Also insider at

RNA
Avidity Biosciences, Inc. Healthcare
EM

Eric Mosbrooker

SVP, Orphan Business Unit
Dublin, L2

Track Institutional and Insider Activities on HZNP

Follow Horizon Therapeutics Public Ltd Co and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HZNP shares.

Notify only if

Insider Trading

Get notified when an Horizon Therapeutics Public LTD CO insider buys or sells HZNP shares.

Notify only if

News

Receive news related to Horizon Therapeutics Public Ltd Co

Track Activities on HZNP